Seeking Alpha
Research analyst, IPOs, long/short equity
Profile| Send Message|
( followers)  

The following IPOs are expected to price this week:

AcelRx (NASDAQ:ACRX), a biotech developing a Phase 3 treatment for acute post-operative pain, plans to raise $75 million by offering 5.8 million shares at a price range of $12 to $14. At the mid-point of the proposed range, AcelRx will command a market value of $210 million. AcelRx, which was founded in 2005, has yet to generate product revenue. The Redwood City, CA-based company plans to list on the NASDAQ under the symbol ACRX. Piper Jaffray (NYSE:PJC) is the lead underwriter on the deal.

China Century Dragon Media (NYSEMKT:CDM)
, a TV advertising company in China that resells ad time on China Central Television, plans to raise $7 million by offering 2.5 million shares at a price range of $3 to $4. At the mid-point of the proposed range, China Century Dragon Media will command a market value of $46 million. Cina Century Dragon Media, which was founded in 2007, booked $106 million in sales over the last 12 months. The Huizhou City-based company plans to list on the NYSE under the symbol CDM. WestPark Capital and i-Bankers Securities are the lead underwriters on the deal.

Clarus Therapeutics (CLRS)
, a biotech with an oral testosterone replacement therapy entering Phase 3, plans to raise $60 million by offering 5 million shares at a price range of $11 to $13. At the mid-point of the proposed range, Clarus Therapeutics will command a market value of $218 million. Clarus Therapeutics, which was founded in 2003, has yet to generate product revenue. The Northbrook, IL-based company plans to list on the NASDAQ under the symbol CLRS. Piper Jaffray and Wells Fargo Securities (NYSE:WFC) are the lead underwriters on the deal.

Fluidigm (NASDAQ:FLDM)
, which makes high-throughput sequencing devices and consumables for genetic labs, plans to raise $75 million by offering 5.2 million shares at a price range of $13.50 to $15.50. At the mid-point of the proposed range, Fluidigm will command a market value of $291 million. Fluidigm, which was founded in 1999, booked $31 million in sales over the last 12 months. The South San Francisco, CA-based company plans to list on the NASDAQ under the symbol FLDM. Deutsche Bank Securities and Piper Jaffray are the lead underwriters on the deal.

Gevo (NASDAQ:GEVO), which makes biobased alternatives to petroleum-based chemicals and fuels, plans to raise $100 million by offering 7.15 million shares at a price range of $13 to $15. At the mid-point of the proposed range, Gevo will command a market value of $394 million. Gevo, which was founded in 2005, booked $2 million in sales over the last 12 months. The Englewood, CO-based company plans to list on the NASDAQ under the symbol GEVO. UBS Investment Bank (NYSE:UBS), Piper Jaffray and Citi (NYSE:C) are the lead underwriters on the deal.

Imperial Holdings (NYSE:IFT), a specialty finance firm originating loans collateralized by life insurance policies, plans to raise $183 million by offering 16.7 million shares at a price range of $10 to $12. At the mid-point of the proposed range, Imperial Holdings will command a market value of $304 million. Imperial Holdings, which was founded in 2006, booked $97 million in pro forma sales over the last 12 months. The Boca Raton, FL-based company plans to list on the NYSE under the symbol IFT. FBR Capital Markets (FBCM), JMP Securities (NYSE:JPM) and Wunderlich Securities are the lead underwriters on the deal.

Kinder Morgan (NYSE:KMI)
, which holds GP/LP interests in midstream energy LP Kinder Morgan Energy Partners, plans to raise $2.2 billion by offering 80 million shares at a price range of $26 to $29. At the mid-point of the proposed range, Kinder Morgan will command a market value of $19.4 billion. Kinder Morgan, which was founded in 1992, booked $8.2 billion in sales over the last 12 months. The Houston, TX-based company plans to list on the NYSE under the symbol KMI. Goldman, Sachs & Co. (NYSE:GS) and Barclays Capital (NYSE:BCS) are the lead underwriters on the deal.

Kips Bay Medical (NASDAQ:KIPS), which offers vein support technology used in coronary artery bypass surgery, plans to raise $25 million by offering 2.75 million shares at a price range of $8 to $10. At the mid-point of the proposed range, Kips Bay Medical will command a market value of $147 million. Kips Bay Medical, which was founded in 2007, has yet to generate product revenue. The Minneapolis, MN-based company plans to list on the NASDAQ under the symbol KIPS. Rodman & Renshaw and Newbridge Securities are the lead underwriters on the deal.

Summit Hotel Properties (NYSE:INN), a self-advised REIT with a portfolio of 65 limited/select service hotels in 19 states, plans to raise $265 million by offering 23 million shares at a price range of $10.50 to $12.50. At the mid-point of the proposed range, Summit Hotel Properties will command a market value of $394 million. Summit Hotel Properties, which was founded in 2004, booked $121 million in pro forma sales over the last 12 months. The Sioux Falls, SD-based company plans to list on the NYSE under the symbol INN. Deutsche Bank Securities (NYSE:DB), Baird and RBC Capital Markets are the lead underwriters on the deal.

The Aveon Group L.P. (AVO)
, an investment firm formed to acquire interests in a group of hedge funds, plans to raise $236 million by offering 15.7 million shares at a price range of $14 to $16. At the mid-point of the proposed range, The Aveon Group L.P. will command a market value of $294 million. The Aveon Group L.P., which was founded in 2010, booked $58 million in pro forma sales over the last 12 months. The Marblehead, MA-based company plans to list on the NYSE under the symbol AVO. J.P. Morgan (JPM), Jefferies & Co. (JEF) and BMO Capital Markets are the lead underwriters on the deal.

Zuoan Fashion Limited (NYSE:ZA), a Chinese designer and distributor of casual menswear through 1,075 retail outlets, plans to raise $79 million by offering 6.9 million shares at a price range of $10.50 to $12.50. At the mid-point of the proposed range, Zuoan Fashion will command a market value of $326 million. Zuoan Fashion Limited, which was founded in 1999, booked $104 million in sales over the last 12 months. The Shanghai-based company plans to list on the NYSE under the symbol ZA. Cowen & Company (NASDAQ:COWN) is the lead underwriter on the deal.

Last week, there were 8 IPO pricings. Epocrates (NASDAQ:EPOC), which provides an ad-supported mobile drug reference app for healthcare professionals, was the week's winner, ending up 66% from its IPO price.

Source: 11 IPOs on Tap for This Week